Le Lézard
Classified in: Business
Subject: BOARD OF DIRECTORS

WisdomTree Defies Will of Stockholders with Appointment of Win Neuger as Board Chair


Board Rejects Opportunity to Demonstrate True Board Refreshment and Delivers a Rebuke to Stockholders

WisdomTree Stockholders Should Voice their Views to the Board and not Accept Another Year of Business as Usual

NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- ETFS Capital Limited ("ETFS Capital"), the largest combined owner of common stock, $0.01 par value (the "Common Stock"), and Series A Non-Voting Convertible Preferred Stock (the "Series A Preferred Stock") of WisdomTree, Inc. ("WisdomTree" or the "Company") (NYSE: WT), with ownership of approximately 10.2% of the outstanding Common Stock, which together with its Series A Preferred Stock would represent approximately 18.3% of the Company's outstanding Common Stock on an as-converted basis, today commented on the the WisdomTree board of director's (the "Board") decision to appoint long-tenured director, Win Neuger as Chair of the Board.

Mr. Neuger received the most withheld votes of any incumbent director at the 2023 annual meeting of stockholders, other than the Company's previous Chair Frank Salerno, who failed to be reelected to the Board. Mr. Neuger's appointment as Chair, is a rebuke to stockholders who, along with proxy advisor Institutional Shareholder Services ("ISS") in its report, sent a clear message to WisdomTree that urgent and meaningful Board change was required.

In appointing Mr. Neuger as Chair, the Board has once again rejected an opportunity to demonstrate a commitment to true Board refreshment. As highlighted by ISS, and reflected in the significant withheld votes for Mr. Neuger and Mr. Salerno, the Board continues to maintain a two-tiered structure where only long-tenured and non-diverse directors hold key Board and committee roles. The Board could have easily chosen to elevate directors who are not part of the long-tenured cohort, to key leadership roles. ETFS Capital believes these more recent additions to the Board are more likely to act as independent fiduciaries for stockholders, who can hold management to account.

ETFS Capital calls on its fellow WisdomTree stockholders to voice their views to the Board, who despite any assurances they may have made in their recent campaign, have demonstrated once again that they cannot be trusted to do the right thing for stockholders.

About ETFS Capital Limited

ETFS Capital is a London-based strategic investment company focused on growth opportunities across the ETF ecosystem. As part of its investment process, ETFS Capital receives and analyses many dozens of business ideas and proposals within the ETF ecosphere each year and conducts in-depth technical and commercial due diligence on the companies where it chooses to deploy capital. Thereafter it engages in a hands-on approach, as a partner to management teams and Boards bringing its unparalleled industry-specific expertise for the benefit of those companies.

Investor Contact:

ETFS Capital:

Martyn James
+44 (0) 207-509-0674

or

+1 347 566 8291
[email protected]

Media Contact:

Dan Gagnier / Riyaz Lalani
+1-646-569-5897
[email protected] 



These press releases may also interest you

at 22:00
SAP SE today announced NEC Corporation (TSE: 6701 "NEC") has selected SAP S/4HANA Cloud through the RISE with SAP solution, running on Amazon Web Services (AWS). Together with implementation partner ABeam Consulting, the migration will leverage...

at 21:35
Foundry 415 Innovation Group has unveiled its new Startup BoostCamp workshop series designed to empower startups with the knowledge and strategies they need to overcome the most common challenges to scaling and achieving success in the US market....

at 21:05
Pomerantz LLP is investigating claims on behalf of investors of Primerica, Inc. ("Primerica" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  ...

at 21:01
Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") .  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 21:00
ZIMLog, a global freight forwarding brand, proudly unveils its renewed structure, reflecting a blend of experience and innovation aimed at meeting the diverse and evolving needs of businesses worldwide. After more than 22 years of successful...

at 20:55
Pomerantz LLP is investigating claims on behalf of investors of Reviva Pharmaceuticals Holdings, Inc. ("Reviva" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980...



News published on and distributed by: